M
MRVI
Maravai Lifesciences Holdings, I…
4.400
-0.080-1.79%After Hours: 4.580 +0.180 +4.09%18:52 05/22 EDT
OPEN/PREV CLOSE4.480/4.480
TODAY RANGE4.341-4.520
VOL2.24M
MARKET CAP1.14B
52 WEEK RANGE1.990-4.995
AVG VOL (3M)2.12M
% TURNOVER0.87%
TURNOVER--
P/E (TTM)-6.0900
% RANGE3.99%
EPS(TTM)-0.7225
P/E(FORWARD)-17.2549
P/B5.37
BVPS0.8194
DIVIDEND--
P/S6.06
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP483.32M
SHARES OUTSTANDING258.19M
NEXT EARNINGS08/10-08/14
FREE FLOAT109.84M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·5d ago
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
Simply Wall St·05/14 07:48
Maravai LifeSciences Q1 Turnaround Spurs Rethink Of CleanCap Driven Outlook
TipRanks·05/12 00:31
Maravai Lifesciences Signals Turnaround in Earnings Call
Simply Wall St·05/09 02:35
Maravai LifeSciences Holdings (MRVI) EPS Loss Deepens Narrative On Persistent Profitability Concerns
Benzinga·05/08 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·05/08 16:06
Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank
Dow Jones·05/08 13:44
Maravai LifeSciences Is Maintained at Overweight by Wells Fargo
Dow Jones·05/08 13:44
Maravai LifeSciences Price Target Raised to $5.50/Share From $4.50 by Wells Fargo
TipRanks·05/08 11:26
William Blair Sticks to Its Hold Rating for Maravai Lifesciences Holdings (MRVI)
Seeking Alpha·05/07 21:39
Maravai LifeSciences Holdings GAAP EPS of -$0.02 beats by $0.07, revenue of $65.8M beats by $12.8M